Multiple antithrombotic agents increase the risk of postoperative hemorrhage in dermatologic surgery

Journal of the American Academy of Dermatology

Volumn 58, Issue 5, 2008, Pages 810-816

  Shimizu, Ikue ^a   Jellinek, Nathaniel J ^a   Dufresne, Raymond G ^a   Li, Tianyu ^b   Devarajan, Karthik ^b   Perlis, Clifford ^b  

^a BROWN UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN; WARFARIN;

ARTICLE; CHEMOSURGERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN SURGERY; SURGICAL RISK; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 41949110377     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.01.014     Document Type: Article

References (28)

1. Kovich O., and Otley C.C. Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practices. Dermatol Surg 28 (2002) 513-517
2. Otley C.C. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc 78 (2003) 1392-1396
3. Bonow R.O., Carabello B.A., Kanu C., de Leon Jr. A.C., Faxon D.P., Freed M.D., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease); developed in collaboration with the Society of Cardiovascular Anesthesiologists, endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 (2006) 84-231
4. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article; a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 106 (2002) 1893-1900
5. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). Circulation 113 (2006) 156-175
6. Sabatine M.S., Cannon C.P., Gibson C.M., López-Sendón J.L., Montalescot G., Theroux P., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
7. Hohnloser S.H., and Connolly S.J. Combined antiplatelet therapy in atrial fibrillation: review of the literature and future research avenues. J Cardiovasc Electrophysiol 14 Suppl (2003) S60-S63
8. van Es R.F., Jonker J.J.C., Verheugt F.W.A., Deckers J.W., and Grobbee D.E. Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2 study): a randomized controlled trial. Lancet 360 (2002) 109-113
9. Meade T.W., Brennan P.J., Wilkes H.C., and Zuhrie S.R. The Medical Research Council's general practice research framework: thrombosis prevention trial; randomized trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischemic heart disease in men at increased risk. Lancet 351 (1998) 233-241
10. Steinhubl S.R., Berger P.B., Mann III J.T., Fry E.T., DeLago A., Wilmer C., et al., CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
11. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K., and Clopidogrel in Unstable Angina for Prevention of Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel to addition with aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
12. Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., et al., MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
13. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association council on stroke. Stroke 37 (2006) 577-617
14. Ernst E. The usage of complementary therapies by dermatological patients: a systematic review. Br J Dermatol 142 (2000) 857-861
15. Chang L.K., and Whitaker D.C. The impact of herbal medicines on dermatologic surgery. Dermatol Surg 27 (2001) 759-763
16. Collins S.C., and Dufresne R.G. Dietary supplements in the setting of Mohs surgery. Dermatol Surg 28 (2002) 447-452
17. Alcalay J., and Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue?. Dermatol Surg 30 (2004) 1091-1094
18. Bartlett G.R. Does aspirin affect the outcome of minor cutaneous surgery?. Br J Plast Surg 52 (1999) 214-216
19. Billingsley E.M., and Maloney M.E. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal anti-inflammatory agents: a prospective study. Dermatol Surg 23 (1997) 381-383
20. Kargi E., Babuccu O., Hosnuter M., Babuccu B., and Altinyazar C. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesth Plast Surg 26 (2002) 483-485
21. Stables G., and Lawrence C.M. Management of patients taking anticoagulant, aspirin, non-steroidal anti-inflammatory and other anti-platelet drugs undergoing dermatological surgery. Clin Exp Dermatol 27 (2002) 432-435
22. Schanbacher C.F., and Bennett R.G. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg 26 (2000) 785-789
23. Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg 27 (2001) 756-758
24. Dhiwakar M., Khan N.A., and McClymont L.G. Surgical resection of cutaneous head and neck lesions: does aspirin use increase hemorrhagic risk?. Arch Otolaryngol Head Neck Surg 132 (2006) 1237-1241
25. Syed S., Adams B.B., Liao W., Pipitone M., and Gloster H. A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery. J Am Acad Dermatol 51 (2004) 955-957
26. Alam M., and Goldberg L.H. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg 28 (2002) 992-998
27. Kimyai-Asadi A., Jih M.H., and Goldberg L.H. Perioperative primary stroke: is aspirin cessation to blame?. Dermatol Surg 30 (2004) 1526-1529
28. Kovich O., and Otley C. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 48 (2003) 233-237